Gastroprotective Effect and Cytotoxicity of Labdeneamides with Amino Acids

Abstract

Semisynthetic aromatic amides from Araucaria araucana diterpene acids have been shown to display a relevant gastroprotective effect with low cytotoxicity. The aim of this work was to assess the gastroprotective effect of amino acid amides from imbricatolic acid and its 8 (9)-en isomer in the ethanol/HCl-induced gastric lesions model in mice as well as to determine the cytotoxicity of the obtained compounds on the following human cell lines: normal lung fibroblasts (MRC-5), gastric adenocarcinoma (AGS), and liver hepatocellular carcinoma (Hep G2). The diterpenes 15-acetoxyimbricatolic acid, its 8 (9)-en isomer, 15-hydroxyimbricatolic acid, and the 8 (9)-en derivative, bearing a COOH function at C-19, were used as starting compounds. New amides with C-protected amino acids were prepared. The study reports the effect of a single oral administration of either compound 50 min before the induction of gastric lesions by ethanol/HCl. Some 20 amino acid monoamides were obtained. Dose-response experiments on the glycyl derivatives showed that at a single oral dose of 100 mg/kg, the compounds presented an effect comparable to the reference drug lansoprazole at 20 mg/kg and at 50 mg/kg reduced gastric lesions by about 50 %. All derivatives obtained in amounts > 30 mg were compared at a single oral dose of 50 mg/kg. The best gastroprotective effect was observed for the exomethylene derivatives bearing a valine residue at C-19 either with an acetoxy or free hydroxy group at C-15. The tryptophanyl derivative from the acetate belonging to the 8,9-en series presented selective cytotoxicity against hepatocytes. The glycyl amide of 15-acetoxyimbricatolic acid was the most cytotoxic and less selective compound with IC₅₀ values between 47 and 103 µM for the studied cell lines. This is the first report on the obtention of semisynthetic amino acid amides from labdane diterpenes.

amino acid amides - Araucaria araucana - Araucariaceae - cytotoxicity - gastroprotective effect - labdane diterpenes

References

• 1 Luo J, Nordenvall C, Nyren O, Adami H O, Permert J, Ye W. The risk of pancreatic cancer in patients with gastric or duodenal ulcer disease.  Int J Cancer. 2007;  120 368-372
• 2 Bahmanyar S, Ye W, Dickman P W, Nyren O. Long-term risk of gastric cancer by subsite in operated and unoperated patients hospitalized for peptic ulcer.  Am J Gastroenterol. 2007;  102 1185-1191
• 3 Catalano V, Labianca R, Beretta G D, Gatta G, de Braud F, Van Cutsem E. Gastric cancer.  Crit Rev Oncol Hematol. 2009;  71 127-164
• 4 Departamento de Estadísticas e Información de Salud, Ministerio de Salud, Gobierno de Chile .http://deis.minsal.cl/deis/salidas06/causas06.asp?temp=45_64_AMBOS.htm Accessed May 02, 2010
• 5 Rodríguez J A, Bustamante C, Astudillo L, Schmeda-Hirschmann G. Gastroprotective activity of solidagenone on experimentally induced gastric lesions in rats.  J Pharm Pharmacol. 2002;  54 399-404
• 6 Rodríguez J A, Astudillo L, Schmeda-Hirschmann G. Oleanolic acid promotes healing of acetic acid-induced chronic gastric ulcers in rats.  Pharmacol Res. 2003;  48 291-294
• 7 Rodríguez J A, Theoduloz C, Sánchez M, Razmilic I, Schmeda-Hirschmann G. Gastroprotective and ulcer-healing effect of new solidagenone derivatives in human cell cultures.  Life Sci. 2005;  77 2193-2205
• 8 Rodríguez J A, Theoduloz C, Sánchez M, Yáñez T, Razmilic I, Schmeda-Hirschmann G. Gastroprotective activity of a new semi-synthetic solidagenone derivative in mice.  J Pharm Pharmacol. 2005;  57 265-271
• 9 Schmeda-Hirschmann G, Rodríguez J A, Astudillo L. Gastroprotective activity of the diterpene solidagenone and its derivatives on experimentally induced gastric lesions in mice.  J Ethnopharmacol. 2002;  81 111-115
• 10 Schmeda-Hirschmann G, Astudillo L, Sepúlveda B, Rodríguez J A, Theoduloz C, Yáñez T, Palenzuela J A. Gastroprotective effect and cytotoxicity of natural and semisynthetic labdane diterpenes from Araucaria araucana.  Z Naturforsch C. 2005;  60 511-522
• 11 Farina C, Pinza M, Pifferi G. Synthesis and anti-ulcer activity of new derivatives of glycyrrhetic, oleanolic and ursolic acids.  Farmaco. 1998;  53 22-32
• 12 Onoda Y, Magaribuchi T, Tamaki H. Effects of the new anti-ulcer agent 12-sulfodehydroabietic acid monosodium salt on duodenal alkaline secretion in rats.  Arzneimittelforschung. 1990;  40 576-578
• 13 Onoda Y, Takido M, Magaribuchi T, Tamaki H. Effects of 12-sulfodehydroabietic acid monosodium salt (TA-2711), a new anti-ulcer agent, on gastric mucosal lesions induced by necrotizing agents and gastric mucosal defensive factors in rats.  Jpn J Pharmacol. 1990;  52 631-638
• 14 Pearson J P, Roberts N B. Mucosal protective effects of ecabet sodium: pepsin inhibition and interaction with mucus.  Clin Sci. 2001;  100 411-417
• 15 Wada H, Kodato S, Kawamori M, Morikawa T, Nakai H, Takeda M, Saito S, Onoda Y, Tamaki H. Antiulcer activity of dehydroabietic acid derivatives.  Chem Pharm Bull. 1985;  33 1472-1487
• 16 Schmeda-Hirschmann G, Astudillo L, Rodríguez J A, Theoduloz C, Yáñez T. Gastroprotective effect of the Mapuche crude drug Araucaria araucana resin and its main constituents.  J Ethnopharmacol. 2005;  101 271-276
• 17 Izquierdo R, Astudillo L, Rodríguez J A, Theoduloz C, Palenzuela J A, Schmeda-Hirschmann G. Gastroprotective effect and cytotoxicity of labdeneamides.  Planta Med. 2007;  73 310-317
• 18 Sepúlveda B, Astudillo L, Rodríguez J A, Yáñez T, Theoduloz C, Schmeda-Hirschmann G. Gastroprotective and cytotoxic effect of dehydroabietic acid derivatives.  Pharmacol Res. 2005;  2 429-437
• 19 Lee D Y W, He M, Kondaveti L, Liu-Chen L-Y, Ma Z, Wang Y, Chen Y, Li J-G, Beguin C, Carlezon Jr W A, Cohen B. Synthesis and in vitro pharmacological studies of C(4) modified salvinorin A analogues.  Bioorg Med Chem Lett. 2005;  15 4169-4173
• 20 Lee D Y W, He M, Liu-Chen L-Y, Wang Y, Li J-G, Xu W, Ma Z, Carlezon Jr W A, Cohen B. Synthesis and in vitro pharmacological studies of new C(4) modified salvinorin A analogues.  Bioorg Med Chem Lett. 2006;  16 5498-5502
• 21 Yu D, Sakurai Y, Chen C-H, Chang F-R, Huang L, Kashiwada Y, Lee K-H. Anti-AIDS agents 69. Moronic acid and other triterpene derivatives as novel potent anti-HIV agents.  J Med Chem. 2006;  49 5462-5469
• 22 Areche C, Rodríguez J A, Razmilic I, Yañez T, Theoduloz C, Schmeda-Hirschmann G. Gastroprotective and cytotoxic effect of semisynthetic ferruginol derivatives.  J Pharm Pharmacol. 2007;  59 289-300
• 23 Olfert E D, Cross B M, McWilliam A A. Guide to the care and use of experimental animals, Vol. 1. Ottawa; Canadian Council on Animal Care 1993: 213-214
• 24 Rodríguez J A, Haun M. Cytotoxicity of trans-dehydrocrotonin from Croton cajucara (Euphorbiaceae) on V79 cells and hepatocytes.  Planta Med. 1999;  65 522-526
• 25 Parra A, Rivas F, Lopez P E, Garcia-Granados A, Martinez A, Albericio F, Marquez N, Muñoz E. Solution- and solid-phase synthesis and anti-HIV activity of maslinic acid derivatives containing amino acids and peptides.  Bioorg Med Chem. 2009;  17 1139-1145
• 26 Wu F, Yi Y, Sun P, Zhang D. Synthesis, in vitro inhibitory activity towards COX-2 and haemolytic activity of derivatives of Esculentoside A.  Bioorg Med Chem Lett. 2007;  17 6430-6433
• 27 Wei Y, Ma C-M, Hattori M. Synthesis and evaluation of a-seco type triterpenoids for anti-HIV-1 protease activity.  Eur J Med Chem. 2009;  44 4112-4120
• 28 Silva Melo P, Durán N, Hiruma-Lima C A, Souza-Brito A R M, Haun M. Comparison of the gastroprotective effect of a diterpene lactone isolated from Croton cajucara with its synthetic derivatives.  J Ethnopharmacol. 2003;  87 169-174
• 29 Miyagawa T, Ohtsuki T, Koyano T, Kowithayakorn T, Masami I. Cassaine diterpenoid dimers isolated from Erythrophleum succirubrum with TRAIL-resistance overcoming activity.  Tetrahedron Lett. 2009;  50 4658-4662

1 Dedicated to the memory of Prof. Dr. Jaime A. Rodríguez